Cancer and comorbidity in older patients: a descriptive profile.

In 1992, the National Institute on Aging (NIA) and the National Cancer Institute (NCI) initiated a study to assess the prevalence of comorbid conditions in elderly patients with cancer. Seven cancer sites were selected for the study: breast, cervix, ovary, prostate, colon, stomach, and urinary bladder. This report on approximately 7600 patients in the study sample describes the NIA/NCI approach to developing information on comorbidity in elderly patients and addresses the chronic disease burden (i.e., comorbidity) and severity for six particular conditions: arthritis, chronic obstructive pulmonary disease (COPD), diabetes, gastrointestinal problems, heart-related conditions, and hypertension. Data on comorbidity were collected by abstracting information from hospital medical records. Patients were registered in six geographic areas of the NCI Surveillance, Epidemiology, and End Results (SEER) Program. A stratified random sample of patients aged 55 to 64, 65 to 74, and 75 years or older-with the index cancers were selected. Comorbidity data were matched with data from the conventional SEER monitoring system. Analyses showed that hypertension is the most prevalent condition and is also much more common as a current management problem rather than as history for the NIA/NCI SEER Study patients. Heart conditions varied slightly in the percentage of severity reported, but percentages for all tumors remained within a range of 13 to 26% for current and past categories. A similar range was observed for arthritis, with the higher percentage seen in the current problem category. For episodic complaints (e.g., gastrointestinal problems), a medical history was more common, except for cancers that involve complaints associated with the malignancy (e.g., colon and stomach cancers and, to a lesser extent, ovarian cancer). COPD and diabetes were less prevalent. Analyses currently under way will determine the impact of a patient's comorbidity burden on the cancer care continuum of diagnosis, treatment, and survival. The broad and independent effects of chronic conditions, singly and in combination, are being examined.

[1]  S. Horn.  Facilities , 1983, American journal of public health.

[2]  James V. Jucker,et al.  A Response , 1979 .

[3]  B E Fries,et al.  The accuracy of the National Death Index when personal identifiers other than Social Security number are used. , 1992, American journal of public health.

[4]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[5]  J M Lepkowski,et al.  Comorbidity and its impact on disability. , 1989, The Milbank quarterly.

[6]  R. Yancik,et al.  Caring for elderly cancer patients. Quality assurance considerations , 1989, Cancer.

[7]  G. Coffman,et al.  Predicting In-Hospital Mortality: A Comparison of Severity Measurement Approaches , 1992, Medical care.

[8]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[9]  J. Jollis,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.

[10]  L. Kessler,et al.  Rise in prostatic cancer incidence associated with increased use of transurethral resection. , 1990, Journal of the National Cancer Institute.

[11]  R. Klein,et al.  Use of cardiovascular disease medications and mortality in people with older onset diabetes. , 1992, American journal of public health.

[12]  J. Samet,et al.  Stage at Diagnosis of Cancer Varies With the Age of the Patient , 1986, Journal of the American Geriatrics Society.

[13]  R. Elashoff,et al.  Flaws in mortality data. The hazards of ignoring comorbid disease. , 1988, JAMA.

[14]  F. Holmes,et al.  Cancer Stage‐to‐Age Relationship: Implications for Cancer Screening in the Elderly * , 1981, Journal of the American Geriatrics Society.

[15]  J. C. Brocklehurst,et al.  Geriatric Medicine for Students , 1976 .

[16]  P. Walsh,et al.  Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). , 1994, The Journal of urology.

[17]  Vincent Mor,et al.  Relationship Between Age at Diagnosis and Treatments , 1985, Journal of the American Geriatrics Society.

[18]  R. Yancik,et al.  Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data. , 1986, American journal of obstetrics and gynecology.

[19]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .

[20]  W. Satariano.  Aging, comorbidity, and breast cancer survival: an epidemiologic view. , 1993, Advances in experimental medicine and biology.

[21]  P. F. Adams,et al.  Current estimates from the National Health Interview Survey, 1991. , 1992, Vital and health statistics. Series 10, Data from the National Health Survey.

[22]  Mark A. Moskowitz,et al.  A Clinical Assessment of Medis-Groups , 1988 .

[23]  H. Warner,et al.  The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging , 1993, Advances in Experimental Medicine and Biology.

[24]  W. Knaus,et al.  APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Development of APACHE III. , 1989, Critical care medicine.

[25]  M. Charlson.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: A response , 1993 .

[26]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[27]  R. Havlik,et al.  The national institute on aging and the national cancer institute seer collaborative study on comorbidity and early diagnosis of cancer in the elderly , 1994, Cancer.

[28]  R. Severson.  Have transurethral resections contributed to the increasing incidence of prostatic cancer? , 1990, Journal of the National Cancer Institute.

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[30]  G. Coffman,et al.  Chronic conditions and risk of in-hospital death. , 1994, Health services research.

[31]  R. Yancik,et al.  Cancer in the Elderly: Approaches to Early Detection and Treatment , 2004 .

[32]  A. Polednak.  Projected numbers of cancers diagnosed in the US elderly population, 1990 through 2030. , 1994, American journal of public health.

[33]  T. Louis,et al.  Chronic conditions that lead to functional limitation in the elderly. , 1994, Journal of gerontology.

[34]  R. Yancik,et al.  Cancer in older persons. Magnitude of the problem‐how do we apply what we know? , 1994, Cancer.

[35]  Gregory Spencer,et al.  Projections of the Population of the United States, by Age, Sex, and Race: 1983 to 2080. , 1984 .

[36]  L I Iezzoni,et al.  A clinical assessment of MedisGroups. , 1988, JAMA.

[37]  R. Elashoff,et al.  Patterns of care related to age of breast cancer patients. , 1987, JAMA.

[38]  W. Knaus.  The APACHE III Prognostic System , 1992 .

[39]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[40]  P. Wolf,et al.  The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.

[41]  S. Furner,et al.  Medical conditions differentially affect the development of IADL disability: implications for medical care and research. , 1995, The Gerontologist.

[42]  W. Knaus,et al.  APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Implications. , 1989, Critical care medicine.

[43]  Development of APACHE III , 1989 .